Sort
64,565 grants matching “drug discovery”
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2019 · AG
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2021 · AG
High-dimensional Modeling of PET for radiomic Biomarker Discovery
$723,943Ani Eloyan · Brown University · R01 · FY2022 · AG
Supporting New Faculty Recruitment Through Biomedical Research Core Center
$723,908Bernard Mark Evers · University Of Kentucky · P30 · FY2010 · CA
Ceramides in Diastolic Heart Failure
$723,742William L Holland · University Of Utah · R01 · FY2024 · HL
Lead Optimization of DHODH Inhibitors for Malaria
$723,733Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2022 · AI
Molecular of ROMK Channel Function
$723,720Paul A Welling · Johns Hopkins University · R01 · FY2024 · DK
7TMR DRUG DISCOVERY, MICROFLUIDICS &HT FLOW CYTOMETRY
$723,653University Of New Mexico · R24 · FY2002 · EB
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
$723,634David Baker · University Of Washington · R01 · FY2021 · AI
Longitudinal Discovery of Brain Developmental Trajectories
$723,520Michael Peter Milham · Nathan S. Kline Institute For Psych Res · U01 · FY2014 · MH
The Role of Scavenger Receptor gp340 in Mucosal HIV-1 Transmission and Inhibition
$723,472Min Lu · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
Ubiquitin E3 ligase detection by fluorescence resonance transfer
$723,331David E Sterner · Progenra, Inc. · R44 · FY2014 · GM
Targeting the Genus Leishmania with Small Molecules
$723,268Scott Edward Schaus · Boston University (Charles River Campus) · R01 · FY2024 · AI
Detecting pleiotropic effects through integration of omics data
$723,182Andrew Dewan · Yale University · R01 · FY2020 · HL
In vitro core
$723,182F. Michael Hoffmann · University Of Wisconsin-Madison · U19 · FY2020 · AI
Development of SK channel modulators as therapeutic agents for ataxia
$723,140Miao Zhang · Chapman University · R33 · FY2021 · NS
ConProject-001
$723,140Miao Zhang · Chapman University · R33 · FY2021 · NS
Modulating pathogenic T cells in Type 1 diabetes
$722,908Kevan C Herold · Yale University · R01 · FY2024 · DK
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders
$722,756Martin H Teicher · Mclean Hospital · R01 · FY2020 · DA
New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis
$722,728Thomas Dick · Hackensack University Medical Center · U19 · FY2021 · AI
Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer
$722,712Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2021 · CA
Synthetic environmental peptide libraries as a source of novel antibiotics
$722,700Sean F Brady · Hackensack University Medical Center · U19 · FY2019 · AI
Development of vector-specific, resistance-breaking insecticides to reduce malari
$722,567Paul R Carlier · Virginia Polytechnic Inst And St Univ · R01 · FY2010 · AI
Homogeneous Screening Assay for Cytokine Receptor Modulators
$722,532Jeffrey R Spencer · Stategics, Inc. · R44 · FY2019 · TR
Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum
$722,515Joel N Hirschhorn · Boston Children'S Hospital · R01 · FY2024 · DK